The up-and-down nature of the medtech industry continues to carry through 2021, with a recent dip now followed by a rapid ascent. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the week (June 11) at 109.63 points, producing a 2.5% rise from the 106.96-point mark set one […]
Inogen
Inogen appoints BD veteran as chief medical officer
Inogen (NSDQ:INGN) this week announced that it has appointed Dr. Stanislav Glezer as EVP and chief medical officer, effective June 21. Glezer joins the Goleta, Calif.–based oxygen therapy technology company after a stint as worldwide VP of medical affairs for diabetes care at BD. Prior to BD, he served as chief medical officer at Adocia […]
Inogen beats Wall Street EPS consensus by 22¢ in Q1 results
Inogen (NSDQ:INGN) posted first-quarter results yesterday that beat the overall consensus on Wall Street. The Goleta, Calif.-based company reported losses of -$732,000, or -3¢ per share, on sales of $86.932 million for the three months ended March 31, for a sales loss of -1.76% compared with Q1 2020. Earnings per share were -3¢, 22¢ ahead of […]
Inogen names former BD exec as chief commercial officer
Inogen (NSDQ:INGN) announced today that its board of directors appointed George Parr as its EVP and chief commercial officer. Goleta, Calif.–based Inogen’s EVP of marketing, Byron Myers, and EVP of sales, Arron Retterer, announced earlier this month that they plan to leave the portable oxygen therapy company, effective June 4, 2021, following a transition period. […]
Inogen names new CEO
Inogen (NSDQ:INGN) announced that it appointed Nabil Shabshab to serve as its new CEO, effective on Feb. 8, 2021. Additionally, according to a news release, on Jan. 22, Inogen’s board appointed Shabshab to serve as a Class II director of the company, effective Feb. 8, too. His term will expire at the annual meeting of stockholders […]
Inogen CEO announces retirement, commences successor search
Inogen CEO and president Scott Wilkinson announced his intention to retire from both of his positions and as a member of the Board of Directors before the end of next year. Wilkinson plans to remain in his current position until his successor is appointed while assisting the board in the search for his replacement. “On […]
MedTech 100 roundup: Stocks open strong in May
Medtech stocks took a dip as April came to a close, but opened May with a strong week as the COVID-19 pandemic continues to affect the economy. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 83.98 points at the end of last week (May 8). That […]
Inogen plummets after Q1 losses
Inogen (NSDQ:INGN) shares took a big hit today on first-quarter results that beat the consensus forecast despite significant losses. The in-home respiratory product developer saw its shares fall -17.5% at $43.63 per share in mid-morning trading. The Goleta, Calif.-based company posted losses of -$1.6 million, or -7¢ per share, on sales of $83.1 million for the […]
Inogen reports Q4 misses, reduced guidance
Inogen (NSDQ:INGN) shares skyrocketed today on fourth-quarter results that missed the consensus earnings forecast but beat The Street’s sales projections. The Goleta, Calif.-based home oxygen generator maker posted losses of -$1.4 million, or -6¢ per share, on sales of $78.9 million for the three months ended Dec. 31, 2019, sliding into losses after posting profits […]
Inogen dives on Q1 misses, lowered outlook
Shares of Inogen (NSDQ:INGN) came under intense pressure today after the home oxygen generator maker yesterday posted first-quarter results that missed the mark on Wall Street and lowered its top-line outlook for the rest of the year. Goleta, Calif.-based Inogen said profits slid -49.5% to $5.4 million, or 24¢ per share, on sales growth of 15.3% […]
Short-seller Muddy Waters picks new medtech target: Inogen
Shares in Inogen have fallen nearly 3% today after short-selling firm Muddy Waters released a new research report calling into question the portable oxygen concentrator developer’s total addressable market and suggesting the company “created an egregiously false narrative.” In its report, Muddy Waters claims that the total addressable market for Inogen’s products “is actually shrinking,” […]
